Georgios Georgakis - Concepedia

Author

Georgios Georgakis

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

G. Georgakis, G. V. Georgakis, G.V. Georgakis, Georgakis, Georgios, Georgios Georgakis, Georgios V Georgakis, Georgios V. Georgakis

108

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Baylor College of Medicine Stony Brook University George Mason University Stony Brook University Hospital

About

Georgios Georgakis is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	670
2	Engineering	7	7	254
3	Cell Biology	6	6	481
4	Natural Sciences	2	2	23
5	Health Sciences	1	1	103

Georgios Georgakis

Publications

Citations

H-Index

Page 1

	Year	Citations
MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival Bei Zheng, Paolo Fiumara, Yang V. Li, Blood	2003	210
Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL‐R1 and TRAIL‐R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin‐ and bortezomib‐induced cell death Georgios Georgakis, Yang Li, Robin Humphreys, British Journal of Haematology	2005	169
Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines Daniela Buglio, Georgios Georgakis, Shino Hanabuchi, Blood	2008	159
Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma Victor Yazbeck, Daniela Buglio, Georgios Georgakis, Experimental Hematology Cell AutophagyMitophagySignal TransductionMantle Cell LymphomaAutophagy	2008	139
Inhibition of Heat Shock Protein 90 Function by 17-Allylamino-17-Demethoxy-Geldanamycin in Hodgkin's Lymphoma Cells Down-Regulates Akt Kinase, Dephosphorylates Extracellular Signal–Regulated Kinase, and Induces Cell Cycle Arrest and Cell Death Georgios Georgakis, Yang Li, Georgios Z. Rassidakis, Clinical Cancer Research	2006	122
Inhibition of the phosphatidylinositol‐3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma Georgios Georgakis, Yang Li, Georgios Z. Rassidakis, British Journal of Haematology Phosphatidylinositol‐3 Kinase/aktApoptosisImmunologyCell DeathTumor Biology	2005	116
Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-κB Mutations or Activation of the CD30, CD40, and RANK Receptors Bei Zheng, Georgios Georgakis, Yang Li, Clinical Cancer Research	2004	108
The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells Mohammad Luqman, Sha Klabunde, Karen Lin, Blood ImmunologyCell DeathAntileukemia ActivityImmunologic MechanismImmunotherapy	2008	103
Successful Nonoperative Management of the Most Severe Blunt Liver Injuries Gwendolyn M. van der Wilden, George C. Velmahos, Timothy A. Emhoff, Archives of Surgery	2012	93
Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors Annunziata Gloghini, Daniela Buglio, Noor M. Khaskhely, British Journal of Haematology Histone ModificationsHistone DeacetylasesPathologySelective InhibitorsTumor Biology	2009	89

Page 1